Back to Search
DR. BETH KARLAN M.D.
M.D.
Gynecologic Oncology Physician
NPI: 1609859586IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
G57519(CA)
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
G57519(CA)
Education
HARVARD MEDICAL SCHOOL
Class of 1982
Research & Publications (20)
The role of genetic testing for cancer susceptibility in gynecologic practice.
PMID 17601911·Obstet Gynecol·2007
6-review
Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
PMID 19500821·Gynecol Oncol·2009
8-other
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 19103723·J Clin Oncol·2009
8-other
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo.
PMID 18627377·Cancer Sci·2008
7-preclinical
Lymphadenectomy's role in early endometrial cancer: prognostic or therapeutic?
PMID 19033560·J Natl Cancer Inst·2008
8-other
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.
PMID 18413725·Cancer Res·2008
8-other
Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
PMID 18374401·Gynecol Oncol·2008
8-other
Rapid progression of prostate cancer in men with a BRCA2 mutation.
PMID 18577985·Br J Cancer·2008
8-other
Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
PMID 18615678·Genes Chromosomes Cancer·2008
8-other
Functional domains of CCN1 (Cyr61) regulate breast cancer progression.
PMID 18575751·Int J Oncol·2008
8-other
Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.
PMID 19047089·Clin Cancer Res·2008
8-other
Androgens and epithelial ovarian cancer: What's the connection?
PMID 19151584·Cancer Biol Ther·2008
6-review
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.
PMID 18762812·Oncogene·2008
8-other
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers.
PMID 18264087·Nature·2008
8-other
Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology.
PMID 17825390·Gynecol Oncol·2007
8-other
Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.
PMID 16956650·Gynecol Oncol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 6 locations total
- Address
- 120 S Spalding Dr Ste 401
Beverly Hills, CA 90212 - Phone
- (310) 794-3639
Locations (6)
Practice Location
120 S Spalding Dr Ste 401, Beverly Hills, CA
(310) 794-3639
Practice Location
100 Ucla Medical Plaza Suite 383, Los Angeles, CA
(310) 983-1023
Practice Location
200 UCLA MEDICAL PLZ STE 430, LOS ANGELES, CA
(310) 794-7274
Practice Location
8700 BEVERLY BLVD., LOS ANGELES, CA
(310) 423-3302
Practice Location
200 UCLA MEDICAL PLZ STE 220, LOS ANGELES, CA
(310) 794-7274
Practice Location
1245 16TH ST STE 202, SANTA MONICA, CA
(310) 794-7274
Quick Facts
- NPI
- 1609859586
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 6
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile